Is serum anti-cyclic citrullinated peptide level useful in the diagnosis of rheumatoid arthritis?

被引:5
|
作者
Kim, Duck-An [1 ]
Kim, Think-You [1 ]
机构
[1] Hanyang Univ, Med Ctr, Dept Early Arthrit Lab Med, Seoul 133792, South Korea
关键词
Anti-CCP; ELISA; Rheumatoid arthritis; Diagnosis; ANTIPERINUCLEAR FACTOR;
D O I
10.1016/j.cca.2012.01.022
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: To find out whether serum level of anti-cyclic citrullinated peptides (anti-CCP) could be useful in the diagnosis of rheumatoid arthritis (RA). Methods: The study was performed against 1972 patients who visited Hanyang University Medical Center and were tested positive for anti-CCP. Results: When test results were classified into 6 groups according to the anti-CCP level, diagnostic rates of RA in each group were distributed from 73.6% to 77.2%. The increase of serum level did not have any correlation with the diagnostic rate of RA. Conclusions: The level of serum anti-CCP was not useful in the diagnosis of RA. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:831 / 832
页数:2
相关论文
共 50 条
  • [1] The role of anti-cyclic citrullinated peptide and rheumatoid factor in diagnosis of rheumatoid arthritis
    Cheah, Tien E.
    Sockalingam, Sargunan
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2012, 15 (01) : e1 - e1
  • [2] The role of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Diagnosis of Rheumatoid Arthritis
    Mobini, M.
    Kashi, Z.
    Mahdavi, M. R.
    [J]. IRANIAN RED CRESCENT MEDICAL JOURNAL, 2010, 12 (02) : 100 - 103
  • [3] ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES, WHICH ASSAY FOR THE DIAGNOSIS OF RHEUMATOID ARTHRITIS?
    Debaugnies, F.
    Servais, G.
    Badot, V.
    Noubouossie, D.
    Willems, D.
    Corazza, F.
    [J]. ACTA CLINICA BELGICA, 2012, 67 (01): : 65 - 65
  • [4] Anti-cyclic citrullinated peptide antibody is a good indicator for the diagnosis of rheumatoid arthritis
    Wahab, Asrul Abdul
    Mohammad, Marlyn
    Rahman, M. M.
    Said, Mohd. Shahrir Mohamed
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2013, 29 (03) : 773 - 777
  • [5] Prevalence and predicted value of anti-cyclic citrullinated peptide in the diagnosis of rheumatoid arthritis
    Heidari, B.
    Heidari, P.
    [J]. RHEUMATOLOGY, 2006, 45 : I103 - I103
  • [6] Comparison of anti-mutated citrullinated vimentin with anti-cyclic citrullinated peptide and rheumatoid factors for the diagnosis of rheumatoid arthritis
    Song, J. S.
    Park, G. B.
    Park, A. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 369 - 369
  • [7] Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis
    Pinheiro, GC
    Scheinberg, MA
    da Silva, MA
    Maciel, S
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (03) : 234 - 235
  • [8] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    V Michael Holers
    [J]. Nature Clinical Practice Rheumatology, 2006, 2 : 400 - 401
  • [9] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    Holers, V. Michael
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (08): : 400 - 401
  • [10] Serum Vitamin D and Anti-Cyclic Citrullinated Peptide Levels in Rheumatoid Arthritis Patients
    Mohamed, Esmael Faisal
    Ibrahim, Altahir Saeed
    Alkhatim, Mohammed Yassir
    Mohammed, Layla Ahmed
    Musa, Hassan Hussein
    Idris, Alkhair Abd Almahmoud
    [J]. BIOMEDICAL RESEARCH AND THERAPY, 2022, 9 (07): : 5149 - 5153